...
首页> 外文期刊>MBio >Mechanisms of Linezolid Resistance among Coagulase-Negative Staphylococci Determined by Whole-Genome Sequencing
【24h】

Mechanisms of Linezolid Resistance among Coagulase-Negative Staphylococci Determined by Whole-Genome Sequencing

机译:全基因组测序确定凝固酶阴性葡萄球菌对利奈唑胺的耐药机制

获取原文

摘要

Linezolid resistance is uncommon among staphylococci, but approximately 2% of clinical isolates of coagulase-negative staphylococci (CoNS) may exhibit resistance to linezolid (MIC, ≥8?μg/ml). We performed whole-genome sequencing (WGS) to characterize the resistance mechanisms and genetic backgrounds of 28 linezolid-resistant CoNS (21 Staphylococcus epidermidis isolates and 7 Staphylococcus haemolyticus isolates) obtained from blood cultures at a large teaching health system in California between 2007 and 2012. The following well-characterized mutations associated with linezolid resistance were identified in the 23S rRNA: G2576U, G2447U, and U2504A, along with the mutation C2534U. Mutations in the L3 and L4 riboproteins, at sites previously associated with linezolid resistance, were also identified in 20 isolates. The majority of isolates harbored more than one mutation in the 23S rRNA and L3 and L4 genes. In addition, the cfr methylase gene was found in almost half (48%) of S.?epidermidis isolates. cfr had been only rarely identified in staphylococci in the United States prior to this study. Isolates of the same sequence type were identified with unique mutations associated with linezolid resistance, suggesting independent acquisition of linezolid resistance in each isolate. >IMPORTANCE Linezolid is one of a limited number of antimicrobials available to treat drug-resistant Gram-positive bacteria, but resistance has begun to emerge. We evaluated the genomes of 28 linezolid-resistant staphylococci isolated from patients. Multiple mutations in the rRNA and associated proteins previously associated with linezolid resistance were found in the isolates investigated, underscoring the multifocal nature of resistance to linezolid in Staphylococcus. Importantly, almost half the S.?epidermidis isolates studied harbored a plasmid-borne cfr RNA methylase gene, suggesting that the incidence of cfr may be higher in the United States than previously documented. This finding has important implications for infection control practices in the United States. Further, cfr is commonly detected in bacteria isolated from livestock, where the use of phenicols, lincosamides, and pleuromutilins in veterinary medicine may provide selective pressure and lead to maintenance of this gene in animal bacteria.
机译:利奈唑胺在葡萄球菌中并不常见,但是大约2%的临床分离的凝固酶阴性葡萄球菌(CoNS)可能表现出对利奈唑胺的耐药性(MIC,≥8?μg/ ml)。我们进行了全基因组测序(WGS),以表征从中获得的28种耐利奈唑胺的CoNS(21种表皮葡萄球菌分离株和7种溶血性葡萄球菌分离株)的耐药机制和遗传背景。在2007年至2012年间,在加利福尼亚的大型教学卫生系统中进行血液培养。在23S rRNA中鉴定出以下与利奈唑胺抗性相关的特征明确的突变:G2576U,G2447U和U2504A,以及突变C2534U。在以前与利奈唑胺抗性相关的位点,L3和L4核糖蛋白的突变也在20个分离株中得到鉴定。大多数分离株在23S rRNA和L3和L4基因中具有一个以上的突变。此外,在表皮葡萄球菌分离株的近一半(48%)中发现了 cfr 甲基化酶基因。在这项研究之前, cfr 在美国的葡萄球菌中很少被发现。鉴定出具有与利奈唑胺抗性相关的独特突变的相同序列类型的分离株,表明在每个分离物中均独立获得利奈唑胺抗性。 >重要性:利奈唑胺是可用于治疗耐药革兰氏阳性细菌的有限几种抗菌药物之一,但耐药性已开始显现。我们评估了从患者中分离出的28种耐利奈唑胺葡萄球菌的基因组。在所研究的分离物中发现了先前与利奈唑胺抗性相关的rRNA和相关蛋白的多个突变,这突显了葡萄球菌中利奈唑胺抗性的多灶性。重要的是,研究的 S.?epidermidis 分离株中几乎有一半带有质粒携带的 cfr RNA甲基化酶基因,这表明 cfr 的发生可能与在美国比以前记录的要高。这一发现对美国的感染控制实践具有重要意义。此外, cfr 通常在从牲畜分离的细菌中检测到,在兽药中使用酚,林可酰胺和截短侧耳素可在动物细菌中提供选择性压力并导致该基因的维持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号